<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
 <result pre="remains active. Abstract The high mortality rate from the severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in humans and"/>
 <result pre="active. Abstract The high mortality rate from the severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) infections in humans and the"/>
 <result pre="Abstract The high mortality rate from the severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) infections in humans and the lack"/>
 <result pre="rate from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)" exact="infections" post="in humans and the lack of effective therapeutic regime"/>
 <result pre="are the key components of the replication-transcription complex (RTC) to" exact="complete" post="its infectious life cycle. Therefore, targeting these essential viral"/>
 <result pre="key components of the replication-transcription complex (RTC) to complete its" exact="infectious" post="life cycle. Therefore, targeting these essential viral proteins with"/>
 <result pre="to complete its infectious life cycle. Therefore, targeting these essential" exact="viral" post="proteins with small molecules will most likely to halt"/>
 <result pre="proteins with small molecules will most likely to halt the" exact="disease" post="pathogenesis. The lack of experimental structures of these proteins"/>
 <result pre="approved antiviral drugs can be subjected to repurposing against SARS-CoV-2" exact="infection" post="after verifying the in silico results through in vitro"/>
 <result pre="these drugs against SARS-CoV-2. Abbreviations 3CLpro, 3C-like proteinase COVID-19, coronavirus" exact="disease" post="2019 DOPE, discrete optimized protein energy FDA, Food and"/>
 <result pre="GRAVY, grand average of hydropathicity GZR, Grazoprevir MERS-CoV, Middle East" exact="respiratory" post="syndrome coronavirus N7-MTase, S-adenosyl methionine (SAM)-dependent (guanine-N7) methyltransferase Nsps,"/>
 <result pre="grand average of hydropathicity GZR, Grazoprevir MERS-CoV, Middle East respiratory" exact="syndrome" post="coronavirus N7-MTase, S-adenosyl methionine (SAM)-dependent (guanine-N7) methyltransferase Nsps, non-structural"/>
 <result pre="square deviation RTC, replication-transcription complex SAH, S-adenosyl homocysteine SARS-CoV, severe" exact="acute" post="respiratory syndrome coronavirus SARS-CoV-2, severe acute respiratory syndrome coronavirus"/>
 <result pre="deviation RTC, replication-transcription complex SAH, S-adenosyl homocysteine SARS-CoV, severe acute" exact="respiratory" post="syndrome coronavirus SARS-CoV-2, severe acute respiratory syndrome coronavirus 2"/>
 <result pre="RTC, replication-transcription complex SAH, S-adenosyl homocysteine SARS-CoV, severe acute respiratory" exact="syndrome" post="coronavirus SARS-CoV-2, severe acute respiratory syndrome coronavirus 2 SAVES,"/>
 <result pre="S-adenosyl homocysteine SARS-CoV, severe acute respiratory syndrome coronavirus SARS-CoV-2, severe" exact="acute" post="respiratory syndrome coronavirus 2 SAVES, Structure Analysis and Verification"/>
 <result pre="homocysteine SARS-CoV, severe acute respiratory syndrome coronavirus SARS-CoV-2, severe acute" exact="respiratory" post="syndrome coronavirus 2 SAVES, Structure Analysis and Verification Server"/>
 <result pre="SARS-CoV, severe acute respiratory syndrome coronavirus SARS-CoV-2, severe acute respiratory" exact="syndrome" post="coronavirus 2 SAVES, Structure Analysis and Verification Server SF,"/>
 <result pre="antiviral drugs Molecular docking Homology modelling 1 Introduction The coronavirus" exact="disease" post="2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus"/>
 <result pre="1 Introduction The coronavirus disease 2019 (COVID-19) caused by severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed a serious"/>
 <result pre="Introduction The coronavirus disease 2019 (COVID-19) caused by severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) has posed a serious health"/>
 <result pre="The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) has posed a serious health emergency"/>
 <result pre="posed a serious health emergency worldwide. There has been a" exact="total" post="of 5,701,337 confirmed cases and 357,688 deaths due to"/>
 <result pre="pangolin as the intermediary host (Wang et al., 2020). SARS-CoV-2" exact="infections" post="in humans were first reported in late December 2019"/>
 <result pre="from Wuhan, China where the clinical symptoms showed resemblance to" exact="viral pneumonia" post="(Huang et al., 2020). Coronaviruses have a history of"/>
 <result pre="Wuhan, China where the clinical symptoms showed resemblance to viral" exact="pneumonia" post="(Huang et al., 2020). Coronaviruses have a history of"/>
 <result pre="have a history of causing severe epidemics such as the" exact="infections" post="caused by severe acute respiratory syndrome coronavirus (SARS-CoV) during"/>
 <result pre="causing severe epidemics such as the infections caused by severe" exact="acute" post="respiratory syndrome coronavirus (SARS-CoV) during 2002â€&quot;2003 in Guangdong province"/>
 <result pre="severe epidemics such as the infections caused by severe acute" exact="respiratory" post="syndrome coronavirus (SARS-CoV) during 2002â€&quot;2003 in Guangdong province of"/>
 <result pre="epidemics such as the infections caused by severe acute respiratory" exact="syndrome" post="coronavirus (SARS-CoV) during 2002â€&quot;2003 in Guangdong province of China"/>
 <result pre="mortality rate of 11% (Chan-Yeung and Xu, 2003) and the" exact="disease" post="caused by the Middle East respiratory syndrome coronavirus (MERS-CoV)"/>
 <result pre="Xu, 2003) and the disease caused by the Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV) in 2012 which emerged in Saudi"/>
 <result pre="2003) and the disease caused by the Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV) in 2012 which emerged in Saudi Arabia"/>
 <result pre="yet there is currently no clinical treatment available for coronavirus" exact="infections" post="in humans to date (Wu et al., 2020b). SARS"/>
 <result pre="present study is the Nsp14 protein which is important for" exact="viral" post="replication and transcription and is highly conserved within the"/>
 <result pre="al., 2011), the N7-MTase domain helps in assembly of 5â€²" exact="viral" post="mRNA cap structure by addition of a methyl group"/>
 <result pre="organism as â€œHomo sapiensâ€� with taxid: 9606. 2.3 Prediction of" exact="secondary" post="structure elements Garnier-Osguthorpe-Robson (GOR) IV secondary structure prediction method"/>
 <result pre="9606. 2.3 Prediction of secondary structure elements Garnier-Osguthorpe-Robson (GOR) IV" exact="secondary" post="structure prediction method was used to determine the secondary"/>
 <result pre="IV secondary structure prediction method was used to determine the" exact="secondary" post="structure elements of Nsp13 and Nsp14 using their respective"/>
 <result pre="using their respective amino acid sequences. The prediction of protein" exact="secondary" post="structure elements by GOR IV is based on information"/>
 <result pre="ProtParam tool (https://web.expasy.org/protparam/). 2.6In silico homology modelling Due to the" exact="absence of" post="the three-dimensional structure of SARS-CoV-2 helicase and Nsp14 in"/>
 <result pre="(Eswar et al., 2006; Fiser and Å ali, 2003). A" exact="total" post="of five in silico models for each target was"/>
 <result pre="5.0 (https://servicesn.mbi.ucla.edu/SAVES/) and the two last parameters were determined using" exact="Protein" post="Structure Analysis (ProSA)-web server (https://prosa.services.came.sbg.ac.at/prosa.php) by submitting the model"/>
 <result pre="likely to show minimum cross-reactivity with the human proteins. 3.2" exact="Secondary" post="structure analysis Secondary structure analysis for Nsp13 helicase enzymes"/>
 <result pre="minimum cross-reactivity with the human proteins. 3.2 Secondary structure analysis" exact="Secondary" post="structure analysis for Nsp13 helicase enzymes shows that 17.64%,"/>
 <result pre="0.00055 and 0.00095 for Nsp13 helicase and nsp14 respectively. The" exact="total" post="probability that the N-terminus is on the cytoplasmic side"/>
 <result pre="Both Nsp13 helicase and Nsp14 protein were found to be" exact="stable" post="with an instability index of 33.31 and 28.85 respectively."/>
 <result pre="527 Molecular weight (kDa) 66.85 59.82 Theoretical pI 8.66 7.80" exact="Total" post="number of negatively charged residues (GluÂ +Â Asp) 52"/>
 <result pre="number of negatively charged residues (GluÂ +Â Asp) 52 50" exact="Total" post="number of positively charged residues (LysÂ +Â Arg) 64"/>
 <result pre="a resolution of 3.33Â Ã…. The template structure has a" exact="total" post="score of 1071, query coverage of 100%, E-value of"/>
 <result pre="amino acid residues (Gurung and Bhattacharjee, 2017) shows that the" exact="total" post="number of residues in most favoured regions for Nsp13"/>
 <result pre="Table 3). In case of Nsp14 and its template, the" exact="total" post="number of residues in most favoured regions were 422"/>
 <result pre="(Suppl. Fig. 7Câ€&quot;D). The Z-score measures the deviation of the" exact="total" post="energy of the protein structure concerning an energy distribution"/>
 <result pre="residues represented by white characters inside the red box. The" exact="secondary" post="elements such as Î±-helices and 310-helices (Î·) are rendered"/>
 <result pre="residues represented by white characters inside the red box. The" exact="secondary" post="elements such as Î±-helices and 310-helices (Î·) are rendered"/>
 <result pre="among the 16 non-structural proteins formed from the processing of" exact="viral" post="replicative polyproteins-pp1a and pp1ab. These two proteins are the"/>
 <result pre="pp1ab. These two proteins are the key components of the" exact="viral" post="replication and transcription complexes which are essential for the"/>
 <result pre="domain. Because of the indispensability of both the proteins to" exact="complete" post="the life cycle of the coronavirus, they are promising"/>
 <result pre="Nsp13 helicase and Nsp14 is a challenge. However, in the" exact="absence of" post="experimental structures of the target proteins, a bioinformatics approach"/>
 <result pre="antibacterial drugs- lymecycline, cefsulodine and rolitetracycline, anti-fungal drug itraconazole, anti-human" exact="immunodeficiency" post="virus-1 (HIV-1) drug saquinavir, anti-coagulant drug dabigatran, diuretic drug"/>
 <result pre="lead molecules are accepted drugs which are potent inhibitors of" exact="hepatitis C" post="virus (HCV) NS3/4A protease (De Clercq and Li, 2016)."/>
 <result pre="and further can disrupt the RTC machinery thereby impeding the" exact="infectious" post="cycle of the coronavirus. The present study would pave"/>
 <result pre="and interactions of many proteins drive the pathogenesis of the" exact="disease" post="and blocking one target might be less effective. Previously,"/>
 <result pre="antivirals and concluded that design of dual inhibitors against the" exact="viral" post="Main protease (Mpro) and the host calpains/cathepsins might be"/>
 <result pre="be attainable given that both of which are essential for" exact="viral" post="replication. The studies further highlighted an additional benefit of"/>
 <result pre="VelthuisA.J.W.SnijderE.J.WeissS.EoffR.L.SinghK.SarafianosS.G.Mechanism of nucleic acid unwinding by SARS-CoV helicasePLoS One72012 AdedejiA.O.SinghK.CalcaterraN.E.DeDiegoM.L.EnjuanesL.WeissS.SarafianosS.G.Severe" exact="acute" post="respiratory syndrome coronavirus replication inhibitor that interferes with the"/>
 <result pre="of nucleic acid unwinding by SARS-CoV helicasePLoS One72012 AdedejiA.O.SinghK.CalcaterraN.E.DeDiegoM.L.EnjuanesL.WeissS.SarafianosS.G.Severe acute" exact="respiratory" post="syndrome coronavirus replication inhibitor that interferes with the nucleic"/>
 <result pre="nucleic acid unwinding by SARS-CoV helicasePLoS One72012 AdedejiA.O.SinghK.CalcaterraN.E.DeDiegoM.L.EnjuanesL.WeissS.SarafianosS.G.Severe acute respiratory" exact="syndrome" post="coronavirus replication inhibitor that interferes with the nucleic acid"/>
 <result pre="inhibitor that interferes with the nucleic acid unwinding of the" exact="viral" post="helicaseAntimicrob. Agents Chemother.5620124718472822733076 AdedejiA.O.SinghK.KassimA.ColemanC.M.ElliottR.WeissS.R.FriemanM.B.SarafianosS.G.Evaluation of SSYA10-001 as a replication"/>
 <result pre="Chemother.5620124718472822733076 AdedejiA.O.SinghK.KassimA.ColemanC.M.ElliottR.WeissS.R.FriemanM.B.SarafianosS.G.Evaluation of SSYA10-001 as a replication inhibitor of severe" exact="acute" post="respiratory syndrome, mouse hepatitis, and Middle East respiratory syndrome"/>
 <result pre="AdedejiA.O.SinghK.KassimA.ColemanC.M.ElliottR.WeissS.R.FriemanM.B.SarafianosS.G.Evaluation of SSYA10-001 as a replication inhibitor of severe acute" exact="respiratory" post="syndrome, mouse hepatitis, and Middle East respiratory syndrome coronavirusesAntimicrob."/>
 <result pre="of severe acute respiratory syndrome, mouse hepatitis, and Middle East" exact="respiratory" post="syndrome coronavirusesAntimicrob. Agents Chemother.5820144894489824841268 AouadiW.EydouxC.CoutardB.MartinB.DebartF.VasseurJ.J.ContrerasJ.M.MoriceC.QuÃ©ratG.JungM.-L.Toward the identification of viral"/>
 <result pre="severe acute respiratory syndrome, mouse hepatitis, and Middle East respiratory" exact="syndrome" post="coronavirusesAntimicrob. Agents Chemother.5820144894489824841268 AouadiW.EydouxC.CoutardB.MartinB.DebartF.VasseurJ.J.ContrerasJ.M.MoriceC.QuÃ©ratG.JungM.-L.Toward the identification of viral cap-methyltransferase"/>
 <result pre="East respiratory syndrome coronavirusesAntimicrob. Agents Chemother.5820144894489824841268 AouadiW.EydouxC.CoutardB.MartinB.DebartF.VasseurJ.J.ContrerasJ.M.MoriceC.QuÃ©ratG.JungM.-L.Toward the identification of" exact="viral" post="cap-methyltransferase inhibitors by fluorescence screening assayAntivir. Res.144201733033928676301 BecaresM.Pascual-IglesiasA.NogalesA.SolaI.EnjuanesL.ZuÃ±igaS.Mutagenesis of"/>
 <result pre="50 yearsClin. Microbiol. Rev.29201669574727281742 DecrolyE.FerronF.LescarJ.CanardB.Conventional and unconventional mechanisms for capping" exact="viral" post="mRNANat. Rev. Microbiol.1020125165 DenisonM.R.GrahamR.L.DonaldsonE.F.EckerleL.D.BaricR.S.Coronaviruses: an RNA proofreading machine regulates"/>
 <result pre="the accuracy and implications of simple methods for predicting the" exact="secondary" post="structure of globular proteinsJ. Mol. Biol.120197897120642007 GuexN.PeitschM.C.SWISS-MODEL and the"/>
 <result pre="proteinsJ. Biochem.881980189518987462208 IvanovK.A.ThielV.DobbeJ.C.van der MeerY.SnijderE.J.ZiebuhrJ.Multiple enzymatic activities associated with severe" exact="acute" post="respiratory syndrome coronavirus helicaseJ. Virol.7820045619563215140959 JangK.J.LeeN.-R.YeoW.-S.JeongY.-J.KimD.-E.Isolation of inhibitory RNA"/>
 <result pre="Biochem.881980189518987462208 IvanovK.A.ThielV.DobbeJ.C.van der MeerY.SnijderE.J.ZiebuhrJ.Multiple enzymatic activities associated with severe acute" exact="respiratory" post="syndrome coronavirus helicaseJ. Virol.7820045619563215140959 JangK.J.LeeN.-R.YeoW.-S.JeongY.-J.KimD.-E.Isolation of inhibitory RNA aptamers"/>
 <result pre="IvanovK.A.ThielV.DobbeJ.C.van der MeerY.SnijderE.J.ZiebuhrJ.Multiple enzymatic activities associated with severe acute respiratory" exact="syndrome" post="coronavirus helicaseJ. Virol.7820045619563215140959 JangK.J.LeeN.-R.YeoW.-S.JeongY.-J.KimD.-E.Isolation of inhibitory RNA aptamers against"/>
 <result pre="coronavirus helicaseJ. Virol.7820045619563215140959 JangK.J.LeeN.-R.YeoW.-S.JeongY.-J.KimD.-E.Isolation of inhibitory RNA aptamers against severe" exact="acute" post="respiratory syndrome (SARS) coronavirus NTPase/HelicaseBiochem. Biophys. Res. Commun.366200873874418082623 JiaZ.YanL.RenZ.WuL.WangJ.GuoJ.ZhengL.MingZ.ZhangL.LouZ.Delicate"/>
 <result pre="helicaseJ. Virol.7820045619563215140959 JangK.J.LeeN.-R.YeoW.-S.JeongY.-J.KimD.-E.Isolation of inhibitory RNA aptamers against severe acute" exact="respiratory" post="syndrome (SARS) coronavirus NTPase/HelicaseBiochem. Biophys. Res. Commun.366200873874418082623 JiaZ.YanL.RenZ.WuL.WangJ.GuoJ.ZhengL.MingZ.ZhangL.LouZ.Delicate structural"/>
 <result pre="Virol.7820045619563215140959 JangK.J.LeeN.-R.YeoW.-S.JeongY.-J.KimD.-E.Isolation of inhibitory RNA aptamers against severe acute respiratory" exact="syndrome" post="(SARS) coronavirus NTPase/HelicaseBiochem. Biophys. Res. Commun.366200873874418082623 JiaZ.YanL.RenZ.WuL.WangJ.GuoJ.ZhengL.MingZ.ZhangL.LouZ.Delicate structural coordination"/>
 <result pre="NTPase/HelicaseBiochem. Biophys. Res. Commun.366200873874418082623 JiaZ.YanL.RenZ.WuL.WangJ.GuoJ.ZhengL.MingZ.ZhangL.LouZ.Delicate structural coordination of the severe" exact="acute" post="respiratory syndrome coronavirus Nsp13 upon ATP hydrolysisNucleic Acids Res.4720196538655031131400"/>
 <result pre="Biophys. Res. Commun.366200873874418082623 JiaZ.YanL.RenZ.WuL.WangJ.GuoJ.ZhengL.MingZ.ZhangL.LouZ.Delicate structural coordination of the severe acute" exact="respiratory" post="syndrome coronavirus Nsp13 upon ATP hydrolysisNucleic Acids Res.4720196538655031131400 KimS.ThiessenP.A.BoltonE.E.ChenJ.FuG.GindulyteA.HanL.HeJ.HeS.ShoemakerB.A.WangJ.YuB.ZhangJ.BryantS.H.PubChem"/>
 <result pre="Res. Commun.366200873874418082623 JiaZ.YanL.RenZ.WuL.WangJ.GuoJ.ZhengL.MingZ.ZhangL.LouZ.Delicate structural coordination of the severe acute respiratory" exact="syndrome" post="coronavirus Nsp13 upon ATP hydrolysisNucleic Acids Res.4720196538655031131400 KimS.ThiessenP.A.BoltonE.E.ChenJ.FuG.GindulyteA.HanL.HeJ.HeS.ShoemakerB.A.WangJ.YuB.ZhangJ.BryantS.H.PubChem substance"/>
 <result pre="transmembrane protein topology with a hidden Markov model: application to" exact="complete" post="genomesJ. Mol. Biol.305200156758011152613 KyteJ.DoolittleR.F.A simple method for displaying the"/>
 <result pre="Sci.11220159436944126159422 MaC.SaccoM.D.HurstB.TownsendJ.A.HuY.SzetoT.ZhangX.TarbetB.MartyM.T.ChenY.WangJ.Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2" exact="viral" post="replication by targeting the viral main proteaseCell Res.30202067869210.1038/s41422-020-0356-z32541865 MarcotrigianoJ.GingrasA.-C.SonenbergN.BurleyS.K.Cocrystal"/>
 <result pre="inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the" exact="viral" post="main proteaseCell Res.30202067869210.1038/s41422-020-0356-z32541865 MarcotrigianoJ.GingrasA.-C.SonenbergN.BurleyS.K.Cocrystal structure of the messenger RNA"/>
 <result pre="research and analysisJ. Comput. Chem.2520041605161210.1002/jcc.2008415264254 PrenticeE.McAuliffeJ.LuX.SubbaraoK.DenisonM.R.Identification and characterization of severe" exact="acute" post="respiratory syndrome coronavirus replicase proteinsJ. Virol.7820049977998615331731 SinghalT.A review of"/>
 <result pre="and analysisJ. Comput. Chem.2520041605161210.1002/jcc.2008415264254 PrenticeE.McAuliffeJ.LuX.SubbaraoK.DenisonM.R.Identification and characterization of severe acute" exact="respiratory" post="syndrome coronavirus replicase proteinsJ. Virol.7820049977998615331731 SinghalT.A review of coronavirus"/>
 <result pre="analysisJ. Comput. Chem.2520041605161210.1002/jcc.2008415264254 PrenticeE.McAuliffeJ.LuX.SubbaraoK.DenisonM.R.Identification and characterization of severe acute respiratory" exact="syndrome" post="coronavirus replicase proteinsJ. Virol.7820049977998615331731 SinghalT.A review of coronavirus disease-2019"/>
 <result pre="SipplM.J.Recognition of errors in three-dimensional structures of proteinsProteins17199335536210.1002/prot.3401704048108378 TannerJ.A.WattR.M.ChaiY.-B.LuL.-Y.LinM.C.PeirisJ.S.M.PoonL.L.M.KungH.-F.HuangJ.-D.The severe" exact="acute" post="respiratory syndrome (SARS) coronavirus NTPase/helicase belongs to a distinct"/>
 <result pre="of errors in three-dimensional structures of proteinsProteins17199335536210.1002/prot.3401704048108378 TannerJ.A.WattR.M.ChaiY.-B.LuL.-Y.LinM.C.PeirisJ.S.M.PoonL.L.M.KungH.-F.HuangJ.-D.The severe acute" exact="respiratory" post="syndrome (SARS) coronavirus NTPase/helicase belongs to a distinct class"/>
 <result pre="errors in three-dimensional structures of proteinsProteins17199335536210.1002/prot.3401704048108378 TannerJ.A.WattR.M.ChaiY.-B.LuL.-Y.LinM.C.PeirisJ.S.M.PoonL.L.M.KungH.-F.HuangJ.-D.The severe acute respiratory" exact="syndrome" post="(SARS) coronavirus NTPase/helicase belongs to a distinct class of"/>
 <result pre="NTPase/helicase belongs to a distinct class of 5â€² to 3â€²" exact="viral" post="helicasesJ. Biol. Chem.2782003395783958210.1074/jbc.C30032820012917423 ThielV.IvanovK.A.PuticsA.HertzigT.SchelleB.BayerS.WeiÃŸbrichB.SnijderE.J.RabenauH.DoerrH.W.Mechanisms and enzymes involved in SARS"/>
</results>
